142 related articles for article (PubMed ID: 17172031)
1. [Protective immune response of guinea pigs against challenge with foot and mouth disease virus by immunization with foliar extracts from transgenic tomato plants expressing the FMDV structural protein VP1].
Pan L; Zhang YG; Wang YL; Wang BQ; Xie QG
Wei Sheng Wu Xue Bao; 2006 Oct; 46(5):796-801. PubMed ID: 17172031
[TBL] [Abstract][Full Text] [Related]
2. Foliar extracts from transgenic tomato plants expressing the structural polyprotein, P1-2A, and protease, 3C, from foot-and-mouth disease virus elicit a protective response in guinea pigs.
Pan L; Zhang Y; Wang Y; Wang B; Wang W; Fang Y; Jiang S; Lv J; Wang W; Sun Y; Xie Q
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):83-90. PubMed ID: 18006078
[TBL] [Abstract][Full Text] [Related]
3. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
[TBL] [Abstract][Full Text] [Related]
4. A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants.
Dus Santos MJ; Wigdorovitz A; Trono K; Ríos RD; Franzone PM; Gil F; Moreno J; Carrillo C; Escribano JM; Borca MV
Vaccine; 2002 Jan; 20(7-8):1141-7. PubMed ID: 11803075
[TBL] [Abstract][Full Text] [Related]
5. A recombinant porcine circovirus type 2 expressing the VP1 epitope of the type O foot-and-mouth disease virus is infectious and induce both PCV2 and VP1 epitope antibodies.
Huang L; Zhang F; Tang Q; Wei Y; Wu H; Guo L; Fu Y; Liu C
Appl Microbiol Biotechnol; 2014 Nov; 98(22):9339-50. PubMed ID: 25117547
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco.
Huang Y; Liang W; Wang Y; Zhou Z; Pan A; Yang X; Huang C; Chen J; Zhang D
Viral Immunol; 2005; 18(4):668-77. PubMed ID: 16359233
[TBL] [Abstract][Full Text] [Related]
7. Expression of VP1 protein of serotype A and O of foot-and-mouth disease virus in transgenic sunnhemp plants and its immunogenicity for guinea pigs.
Rao JP; Agrawal P; Mohammad R; Rao SK; Reddy GR; Dechamma HJ; S Suryanarayana VV
Acta Virol; 2012; 56(2):91-9. PubMed ID: 22720698
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
[TBL] [Abstract][Full Text] [Related]
9. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
[TBL] [Abstract][Full Text] [Related]
10. Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.
Fan H; Tong T; Chen H; Guo A
Virus Genes; 2007 Oct; 35(2):347-57. PubMed ID: 17497212
[TBL] [Abstract][Full Text] [Related]
11. Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes.
Yang CD; Liao JT; Lai CY; Jong MH; Liang CM; Lin YL; Lin NS; Hsu YH; Liang SM
BMC Biotechnol; 2007 Sep; 7():62. PubMed ID: 17900346
[TBL] [Abstract][Full Text] [Related]
12. Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus.
Li YG; Tian FL; Gao FS; Tang XS; Xia C
Vaccine; 2007 Jan; 25(5):902-11. PubMed ID: 17028078
[TBL] [Abstract][Full Text] [Related]
13. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
Qian P; Li XM; Jin ML; Peng GQ; Chen HC
Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1.
Wigdorovitz A; Pérez Filgueira DM; Robertson N; Carrillo C; Sadir AM; Morris TJ; Borca MV
Virology; 1999 Nov; 264(1):85-91. PubMed ID: 10544132
[TBL] [Abstract][Full Text] [Related]
15. Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus.
Fang M; Li J; Wang H; Yang M; Zhang Y; Zhou L; Wei H; Yang G; Yu Y; Wei X; Yu Y; Wang L; Wan M
Biotechnol Lett; 2012 May; 34(5):839-47. PubMed ID: 22286179
[TBL] [Abstract][Full Text] [Related]
16. B cell epitopes within VP1 of type O foot-and-mouth disease virus for detection of viral antibodies.
Gao SD; Du JZ; Chang HY; Cong GZ; Shao JJ; Lin T; Song S; Xie QG
Virol Sin; 2010 Feb; 25(1):18-26. PubMed ID: 20960280
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the Immunogenicity of recombinant VP1 protein from the foot-and-mouth disease virus encapsulated in nanoliposome in guinea pig animal model.
Kazemi M; Aghamaali MR; Madani R; Emami T; Golchinfar F
Vet Immunol Immunopathol; 2022 Nov; 253():110497. PubMed ID: 36327944
[TBL] [Abstract][Full Text] [Related]
18. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71.
Chen HF; Chang MH; Chiang BL; Jeng ST
Vaccine; 2006 Apr; 24(15):2944-51. PubMed ID: 16448730
[TBL] [Abstract][Full Text] [Related]
19. Protection against Foot-and-Mouth Disease Virus in Guinea Pigs via Oral Administration of Recombinant Lactobacillus plantarum Expressing VP1.
Wang M; Pan L; Zhou P; Lv J; Zhang Z; Wang Y; Zhang Y
PLoS One; 2015; 10(12):e0143750. PubMed ID: 26629822
[TBL] [Abstract][Full Text] [Related]
20. Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants.
Carrillo C; Wigdorovitz A; Trono K; Dus Santos MJ; Castañón S; Sadir AM; Ordas R; Escribano JM; Borca MV
Viral Immunol; 2001; 14(1):49-57. PubMed ID: 11270596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
